Machine Learning in Drug Discovery
A special issue of Machine Learning and Knowledge Extraction (ISSN 2504-4990).
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 427
Special Issue Editor
Special Issue Information
Dear Colleagues,
Time consumption, high cost, and great risk, significant attrition rates, among other factors, are hallmarks of drug discovery. Nevertheless, drug discovery has moved into a new paradigm with the introduction of machine learning technologies. Especially, the innovation and sophistication of machine learning algorithms as well as the development of high-throughput computing machines have further expedited the revolution. In fact, machine learning has been extensively applied to tasks including but not limited to homology modeling; hit identification; lead optimization; drug repurposing, de novo drug design; drug absorption, distribution, metabolism, excretion, and toxicity (ADME/Tox) assessments; and drug formulation development.
The objective of this Special Issue is attempting to comprehensively cover all aspects associated with the applications and innovation of machine learning in drug discovery. In addition, it aims to explore the advantages and limitations of every machine learning algorithm and/or scheme. Finally, the future directions of machine learning and their applications will be addressed.
Dr. Max Leong
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Machine Learning and Knowledge Extraction is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- machine learning
- ligand-based drug design
- structure-based drug design, de novo drug design
- drug repurposing
- drug absorption, distribution, metabolism, excretion, and toxicity (ADME/Tox)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
